Everlywell adds investor, board member through $75M secondary sale
After securing the largest venture capital funding round in Austin in 2020, local digital health tech startup  Everlywell Inc. is already making waves in 2021. The startup has landed a new investor, HealthQuest Capital, that has contributed $75 million. The move was a secondary sale that provided liquidity to other existing investors, TechCrunch reported. While the funding round doesn't boost Everlywe ll's $1.3 billion valuation, it has strategic importance because of HealthQuest's experience… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 15, 2021 Category: Pharmaceuticals Authors: Brent Wistrom Source Type: news

NeuroOne Medical Technologies Corporation Closes $12.5 Million Private Placement with Certain Prominent Institutional Investors, Advances Towards Nasdaq Uplisting
EDEN PRAIRIE, Minn., Jan. 15, 2021 -- (Healthcare Sales & Marketing Network) -- NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for pati... Devices, Neurology, Venture Capital NeuroOne Medical Technologies, Evo Cortical Electrode, functional mapping (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2021 Category: Pharmaceuticals Source Type: news

Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund
Fund will provide support for minority-owned early-stage healthcare companies and is a component of Lilly's racial justice efforts INDIANAPOLIS, Jan. 15, 2021 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) today announce... Biopharmaceuticals, Venture Capital Eli Lilly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 15, 2021 Category: Pharmaceuticals Source Type: news

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers
Novel liquid biopsy technology combines machine learning and low-cost cell free DNA genome-wide fragmentation profiles BALTIMORE, Jan. 12, 2021 -- (Healthcare Sales & Marketing Network) -- Delfi Diagnostics, Inc., a pioneering developer of a new class ... Diagnostics, Oncology, Venture Capital Delfi Diagnostics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 12, 2021 Category: Pharmaceuticals Source Type: news

New Firm OMX Ventures, Backed By Billionaire Merieux Family, Comes Out Of Stealth With $150 Million Fund for Bio-Engineering
A new venture firm, OMX Ventures, is out of stealth with its first $150 million fund, the backing of the billionaire Merieux family, and 15 investments in bio-engineering startups. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 12, 2021 Category: Pharmaceuticals Authors: Amy Feldman, Forbes Staff Tags: Manufacturing /manufacturing Business /business Innovation /innovation Healthcare /healthcare Venture Capital /venture-capital Editors' Pick editors-pick Source Type: news

What Could A Healthcare Marketplace Look Like? GoodRx Is Trying To Show Us
GoodRx may be the most powerful patient advocate in America: it operates at national scale, aggregating the purchasing power of millions of individuals to help them find convenient and low cost options for healthcare needs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 12, 2021 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Source Type: news

Chicago home health care startup Dina raises $7M
A Chicago health care startup working to provide better at-home care raised a new round of funding as it grows its software business. Dina, formerly known as PreparedHealth, raised $7 million in a round led by Philadelphia-based Osage Venture Partners. First Trust Capital Partners, along with the startup's existing investors, also participated. The startup has raised $12 million to date. In 2017, Dina raised $4 million in a rou nd that included Chicago Ventures, Pritzker Group Venture Capital and… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 11, 2021 Category: Pharmaceuticals Authors: Katherine Davis Source Type: news

Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Details of Initial Therapeutic Programs to be Shared at the 39th J.P. Morgan Healthcare Conference BOSTON, Jan. 11, 2021 -- (Healthcare Sales & Marketing Network) -- Valo Health LLC (Valo), the technology company working to transform the drug discovery... Biopharmaceuticals, Venture Capital Valo Health (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 11, 2021 Category: Pharmaceuticals Source Type: news

Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
Blacksmith Medicines, a spin-out of Forge Therapeutics, is pioneering a novel metalloenzyme chemistry platform to create new immuno-oncology and inflammation medicines Research collaboration combines Blacksmith's innovative chemistry platform with Lilly... Biopharmaceuticals, Venture Capital Blacksmith Medicines, Eli Lilly, Forge Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 8, 2021 Category: Pharmaceuticals Source Type: news

Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic
Financing accelerates Werewolf's pipeline of systemically delivered, conditionally activated INDUKINE™ molecules into clinical stage development and supports efforts to build a leading immuno-oncology drug discovery and development team CAMBRIDGE, Mass.... Biopharmaceuticals, Oncology, Venture Capital Werewolf Therapeutics, tumor microenvironment, PREDATOR protein (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2021 Category: Pharmaceuticals Source Type: news

Kira Pharmaceuticals Announces $53.5 Million Series B+ Financing to Advance LOGIC Drug Discovery Platform and Pipeline of Complement-targeted Therapies
CAMBRIDGE, Mass. and SUZHOU, China, Jan. 7, 2021 -- (Healthcare Sales & Marketing Network) -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announ... Biopharmaceuticals, Venture Capital Kira Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2021 Category: Pharmaceuticals Source Type: news

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies
OXFORD, England, Jan. 7, 2021 -- (Healthcare Sales & Marketing Network) -- Theolytics, a UK biotech harnessing viruses to combat cancer, today announced the closing of a US $6.8 million (UK £5 million) Series A round. The round was co-led by Epidare... Biopharmaceuticals, Oncology, Venture Capital Theolytics, oncolytic virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 7, 2021 Category: Pharmaceuticals Source Type: news

Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
Myeloid's cell therapy harnesses the innate capabilities of myeloid lineage cells to fight cancer Scientific founders include world-renowned cell therapy & cancer experts Ronald Vale, Ph.D. and Siddhartha Mukherjee, M.D., D.Phil. Co-Founded by Thomas... Biopharmaceuticals, Oncology, Venture Capital Myeloid Therapeutics, lymphoma, glioblastoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 6, 2021 Category: Pharmaceuticals Source Type: news

Flowonix Medical, Inc. and SWK Holdings Corporation Announce Closing of $33 Million Financing
MOUNT OLIVE, N.J., Jan. 4, 2021 -- (Healthcare Sales & Marketing Network) -- Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation (Nasdaq: SWKH), a life sciences f... Devices, Drug Delivery, Venture Capital Flowonix Medical, Prometra, implantable drug delivery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2021 Category: Pharmaceuticals Source Type: news

Google has a financial interest to push the pandemic and the covid-19 vaccine experiments
(Natural News) Google Ventures, the venture-capital arm of Google, is in a position to profit from the Oxford-AstraZeneca covid-19 vaccine. The developers of the vaccine, Adrian Hill and Sarah Gilbert, set up a company called Vaccitech to attract outside investors for their new vaccine projects. Google co-founder Larry Page and his wife Lucy have already... (Source: NaturalNews.com)
Source: NaturalNews.com - January 1, 2021 Category: Consumer Health News Source Type: news

ImmVira Announces Series C Financing with Leading Specialist Investors
SHENZHEN, China, Dec. 31, 2020 -- (Healthcare Sales & Marketing Network) -- ImmVira Group Company ("the Company"), a biotechnology platform dedicated to the development of oncolytic virus("OV") and vector type approaches to create more... Biopharmaceuticals, Oncology, Venture Capital ImmVira Group, oncolytic virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 31, 2020 Category: Pharmaceuticals Source Type: news

AIVITA Biomedical Closes $25 Million Financing Round
IRVINE, Calif., Dec. 29, 2020 -- (Healthcare Sales & Marketing Network) -- AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, has closed its Series B-2 financin... Biopharmaceuticals, Oncology, Venture Capital AIVITA Biomedical, cancer vaccine, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 29, 2020 Category: Pharmaceuticals Source Type: news

State of Health Care Innovation: Local experts mull the future of Houston's life sciences sector
Houston is widely known as the energy capital of the world, but it ’s also a hub of health care and life sciences innovation.  Nearly 40% of all venture capital funding in the Houston metro region from 2015 through 2019 has gone into the health care sector, according to a Greater Houston Partnership analysis of PitchBook data. Houston is home to the Texas Medic al Center, widely considered to be the largest medical center in the world. With a large concentration of clinical researchers, numerous… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 25, 2020 Category: Pharmaceuticals Authors: Chris Mathews Source Type: news

State of Health Care Innovation: Local experts mull the future of Houston's life sciences sector
Houston is widely known as the energy capital of the world, but it ’s also a hub of health care and life sciences innovation.  Nearly 40% of all venture capital funding in the Houston metro region from 2015 through 2019 has gone into the health care sector, according to a Greater Houston Partnership analysis of PitchBook data. Houston is home to the Texas Medic al Center, widely considered to be the largest medical center in the world. With a large concentration of clinical researchers, numerous… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 25, 2020 Category: Biotechnology Authors: Chris Mathews Source Type: news

8 Digital Health Predictions For 2021
One of the silver linings of 2020 is digital health is finally coming into its own. Health has leapfrogged in adoption of technology, which creates new opportunities for digital health startups. Five leading early stage health tech investors shared predictions for the year ahead. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 23, 2020 Category: Pharmaceuticals Authors: Maren Thomas Bannon, Contributor Tags: Venture Capital /venture-capital Innovation /innovation Healthcare /healthcare Source Type: news

Vivace Therapeutics Announces $30 Million Series C Financing to Fund Clinical Programs Targeting the Hippo Pathway
SAN MATEO, Calif., Dec. 16, 2020 -- (Healthcare Sales & Marketing Network) -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, announced today the closing of a $... Biopharmaceuticals, Oncology, Venture Capital, Personnel Vivace Therapeutics, Hippo pathway (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 16, 2020 Category: Pharmaceuticals Source Type: news

Neuron23(TM) Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group
Biotechnology company launches to accelerate development of precision medicines for genetically defined neurological and immunological diseases SOUTH SAN FRANCISCO, Calif., Dec. 16, 2020 -- (Healthcare Sales & Marketing Network) -- Neuron23™ Inc., an e... Biopharmaceuticals, Neurology, Venture Capital Neuron23, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 16, 2020 Category: Pharmaceuticals Source Type: news

Medical-data company Flywheel nearing goal on $15M Series B
Flywheel, a Minneapolis-based software startup that manages data for medical researchers, has raised at least $14 million of a planned Series B round of venture capital according to a Form D filing with the SEC. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 15, 2020 Category: Health Management Authors: Carrigan Miller Source Type: news

Medical-data company Flywheel nearing goal on $15M Series B
Flywheel, a Minneapolis-based software startup that manages data for medical researchers, has raised at least $14 million of a planned Series B round of venture capital according to a Form D filing with the SEC. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 15, 2020 Category: Biotechnology Authors: Carrigan Miller Source Type: news

MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials
On the back of highly promising Phase Ib data, MinervaX has raised financing from leading investors to accelerate development of its novel vaccine through the end of Phase II trials and preparations for Phase III pivotal trials Sanofi Ventures, Wellingt... Biopharmaceuticals, Venture Capital MinervaX, Group B Streptococcus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 15, 2020 Category: Pharmaceuticals Source Type: news

Intellectual Property Monopolies Block Vaccine Access
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, Dec 15 2020 (IPS) Just before the World Health Assembly (WHA), an 18 May open letter by world leaders and experts urged governments to ensure that all COVID-19 vaccines, treatments and tests are patent-free, fairly distributed and available to all, free of charge. Pious promises Leaders of Italy, France, Germany, Norway and the European Commission called for the vaccine to be “produced by the world, for the whole world” as a “global public good of the 21st century”, while China’s President Xi promised a vaccine developed by Chi...
Source: IPS Inter Press Service - Health - December 15, 2020 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Civil Society Development & Aid Economy & Trade Featured Global Headlines Health Human Rights Humanitarian Emergencies Poverty & SDGs TerraViva United Nations Jomo Kwame Sundaram & Anis Chowdhury Source Type: news

Tech Bytes: St. Louis venture capital firm opens Nashville office; Brentwood health tech startup signs national deal
In an effort to keep important happenings from slipping through the cracks, we ’ve created Tech Bytes — a weekly round up of Middle Tennessee startup and tech-related news, capital raises and other activity. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - December 14, 2020 Category: Health Management Authors: Joel Stinnett Source Type: news

Rani Therapeutics Raises $69 Million Series E To Advance Clinical Trials And Manufacturing Of Robotic Pill
SAN JOSE, Calif., Dec. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Rani Therapeutics, a clinical-stage biopharmaceutical company and developer of the RaniPill™ robotic pill, today announced that it has raised $69 million in a Series E financing,... Biopharmaceuticals, Drug Delivery, Venture Capital Rani Therapeutics, RaniPill, robotic pill (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 10, 2020 Category: Pharmaceuticals Source Type: news

Cyrano Therapeutics Raises $12.8 Million to Complete Phase 2 Trial of CYR-064 for the Restoration of Chronic Smell and Flavor Loss
Currently no FDA-approved therapy for this serious condition afflicting over 15 million in the U.S., with prevalence expected to grow dramatically as a consequence of COVID-19 WASHINGTON, Dec. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Cyran... Regenerative Medicine, Venture Capital, Personnel Cyrano Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 10, 2020 Category: Pharmaceuticals Source Type: news

Sirtex Medical announces strategic investment in BlackSwan Vascular, Inc.
Agreement includes investment to support clinical trials for potential first FDA-approved liquid embolic system for a peripheral vascular indication and option to acquire the company WOBURN, Mass., Dec. 9, 2020 -- (Healthcare Sales & Marketing Network) ... Devices, Oncology, Venture Capital Sirtex Medical, BlackSwan Vascular, Lava, liquid embolic, SIR-Spheres (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 9, 2020 Category: Pharmaceuticals Source Type: news

Remix Therapeutics Launches with $81 Million Financing to Develop Small Molecule Therapies Designed to Reprogram RNA Processing
CAMBRIDGE, Mass., Dec. 8, 2020 -- (Healthcare Sales & Marketing Network) -- Remix Therapeutics, a biotechnology company developing small molecule therapies designed to reprogram RNA processing to address the underlying drivers of disease, launched today w... Biopharmaceuticals, Venture Capital Remix Therapeutics, REMaster technology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 8, 2020 Category: Pharmaceuticals Source Type: news

Olive makes $120M acquisition on heels of record funding round
Olive AI Inc. has acquired another healthcare artificial intelligence startup for $120 million, the company said, days after closing a $226 million venture capital round. Verata Health, based in Minneapolis, makes software to automate the process of obtaining authorizations from insurance companies before a medical procedure. Adding its 60 employees, including Boston and Orlando offices, brings Columbus-based Olive close to 500 jobs nationwide, according to a news release. Olive was valued at $1.5… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 4, 2020 Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news

Neuroglee Therapeutics to Attack Alzheimer's Disease Through Personalized AI-Powered Digital Therapeutics
Start-up to leverage gamification and cognitive rehabilitation targeting cognition, mood and behaviors in patients with mild-to-moderate Alzheimer's disease Digital therapeutics solution collects digital biomarkers via computer tablets in the home to as... Devices, Neurology, Venture Capital Neuroglee Therapeutics, digital therapeutics, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 3, 2020 Category: Pharmaceuticals Source Type: news

How Much Impact Can A Small Federal Agency Have On Healthcare Innovation? A Lot, It Seems
A Final Rule With Big Implications The Office of the National Coordinator for Health IT ’’s (ONC’s) final rule on Interoperability, Information Blocking, and ONC Health IT Certification, to be implemented in April 2021 (delayed from November 2020), is designed to give patients and providers secure... (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 2, 2020 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Source Type: news

V Star ’s Bruce Yu Finds Homegrown Success In China Venture Capital
V Star's Bruce Yu earlier in his career worked alongside Forbes Midas List members Jenny Lee and Jinxiu Foo. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 30, 2020 Category: Pharmaceuticals Authors: Russell Flannery, Forbes Staff Tags: Asia /asia Business /business Innovation /innovation Healthcare /healthcare russellflanneryblog Source Type: news

Elevian Announces $15 Million Equity Financing
Company Expands Leadership Team as it Advances Preclinical Studies of rGDF11 in Stroke and Other Age-Related Diseases ALLSTON, Mass., Nov. 24, 2020 -- (Healthcare Sales & Marketing Network) -- Elevian, an emerging biotech company developing medicines t... Biopharmaceuticals, Regenerative Medicine, Venture Capital Elevian, age-related disease, GDF11 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 24, 2020 Category: Pharmaceuticals Source Type: news

OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management
KYOTO, Japan, Nov. 24, 2020 -- (Healthcare Sales & Marketing Network) -- OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65 million series E funding for the lead... Deices, Cardiology, Monitoring, Venture Capital OMRON Healthcare, AliveCor , personal electrocardiogram (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 24, 2020 Category: Pharmaceuticals Source Type: news

SynOx Therapeutics raises €37M in Series A Financing
HealthCap and Medicxi co-lead, joined by Forbion and Gimv Financing to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumours DUBLIN, Nov. 19, 2020 -- (Healthcare Sales & Marketing Network) -- SynOx Therapeutics Lt... Biopharmaceuticals, Oncology, Venture Capital SynOx Therapeutics, Celleron Therapeutics, emactuzumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 19, 2020 Category: Pharmaceuticals Source Type: news

Durham firm Phononic ready to play crucial role in Covid vaccine distribution
As both Pfizer and Moderna inch closer to approved Covid-19 vaccines, companies are lining up to support the effort — including in the Triangle, where innovation could help solve a big challenge for distribution: how to keep the vaccines cold. Phononic, a Durham refrigeration technology firm with more than $160 million in venture capital dollars in its coffers, has already been part of the distribution conver sation, according to Keith Lewis, director of business development and strategic partnerships. “You’d… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 19, 2020 Category: Health Management Authors: Lauren Ohnesorge Source Type: news

The Petri Dish: Wyss Institute's VC partnership and a health tech firm eyes M & A
This week, the Wyss Institute at Harvard University partnered with a venture capital firm and a local AstraZeneca plc spin-out found success in a Phase 3 trial. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - November 19, 2020 Category: Health Management Authors: Allison DeAngelis Source Type: news

Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer
$65M Series B Raise Led by New Investors venBio Partners and Cormorant Asset Management, with Participation by Boxer Capital of Tavistock Group, Janus Henderson, Samsara Biocapital, Vivo Capital, and All Existing Series A Investors Shawn M. Leland, Foun... Biopharmaceuticals, Oncology, Venture Capital, Personnel Elevation Oncology, seribantumab (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2020 Category: Pharmaceuticals Source Type: news

Umoja Biopharma Launches with $53M Series A Financing to Develop Fully Integrated, Scalable, In Vivo Immunotherapy Platform
Umoja's platform addresses key limitations of existing engineered immunotherapies Company backed by prominent life science investors MPM Capital, DCVC Bio and Qiming Venture Partners USA and led by an experienced team of scientist/entrepreneurs SEATT... Biopharmaceuticals, Oncology, Venture Capital Umoja Biopharma, immunotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 18, 2020 Category: Pharmaceuticals Source Type: news

Harvard's Wyss Institute creates alliance with Northpond Labs
(Wyss Institute for Biologically Inspired Engineering at Harvard) Harvard University's Wyss Institute for Biologically Inspired Engineering has established its first research and innovation alliance by joining forces with Northpond Labs, the research and development-focused affiliate of a leading science and technology-driven venture capital firm, Northpond Ventures. Through the alliance, Northpond Labs will provide $12 million to create a Laboratory for Bioengineering Research and Innovation at the Wyss Institute and to support impactful research with strong translation potential. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 18, 2020 Category: International Medicine & Public Health Source Type: news

The Art Of Pitching A Platform Business In Healthcare
2020 has been a banner year for digital platforms in healthcare as well. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 16, 2020 Category: Pharmaceuticals Authors: Seth Joseph, Contributor Tags: Healthcare /healthcare Innovation /innovation Venture Capital /venture-capital Source Type: news

Kira Pharmaceuticals Launches to Pioneer Novel Therapeutics for Complement-Mediated Diseases
$46M in Financing Secured from leading global life science investors Frederick Beddingfield Appointed as CEO CAMBRIDGE, Md. and SUZHOU, China, Nov. 12, 2020 -- (Healthcare Sales & Marketing Network) -- Kira Pharmaceuticals, a global biotechnology co... Biopharmaceuticals, Venture Capital, Personnel Kira Pharmaceuticals, (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 12, 2020 Category: Pharmaceuticals Source Type: news

Pappas Capital founder ready for more big deals as life science innovation thrives
Days after reporting a mammoth portfolio exit, the founder of a Durham-based venture capital firm says the future is bright – both for his firm and the sector. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 11, 2020 Category: American Health Authors: Lauren Ohnesorge Source Type: news

Prometheus Biosciences Announces $130 Million Financing to Advance Precision Medicines for the Treatment of Inflammatory Bowel Disease
New investors include Eventide, RTW, Perceptive Advisors, Cormorant Capital, Cowen Healthcare Investments and Point72 Proceeds to accelerate clinical development of PRA023, a potential best in class TL1A antibody for IBD, and expansion of Promtheus' 360... Biopharmaceuticals, Venture Capital, Personnel Prometheus Biosciences, precision medicine, inflammatory bowel disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2020 Category: Pharmaceuticals Source Type: news

UK's coronavirus vaccine taskforce chief faces questions over biotech fund
Report claims Kate Bingham ’s venture capital firm has invested in companies developing Covid-19 antibody cocktailsCoronavirus – latest updatesSee all our coronavirus coverageThe head of the government ’s vaccine taskforce faces fresh questions after it emerged she hailed the launch of a biotechnology investment fund in her capacity as managing director of a venture capital firm despite having “stepped away” from the role.Kate Bingham, a venture capitalist married to the Conservative minister Jesse Norman, came under scrutiny this week when Labour asked the cabinet secretary to “undertak...
Source: Guardian Unlimited Science - November 8, 2020 Category: Science Authors: Mattha Busby Tags: UK news Coronavirus Science Infectious diseases Venture capital Medical research Microbiology Vaccines and immunisation Source Type: news

CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates
SHANGHAI, Nov. 2, 2020 -- (Healthcare Sales & Marketing Network) -- CARsgen Therapeutics Holdings Limited ("CARsgen"), a leading biotechnology company focused on innovation and development of chimeric antigen receptor (CAR) T-cell therapeutics, ... Biopharmaceuticals, Venture Capital CARsgen Therapeutics, CAR-T, cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 2, 2020 Category: Pharmaceuticals Source Type: news

Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions
PARIS, Nov. 2, 2020 -- (Healthcare Sales & Marketing Network) -- Corlieve Therapeutics today announced the closing of its seed financing led by Kurma Partners and IDinvest Partners, together with Pureos Bioventures. Corlieve is focused on developing novel... Regenerative Medicine, Neurology, Venture Capital Corlieve Therapeutics, gene therapy, temporal lobe epilepsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 2, 2020 Category: Pharmaceuticals Source Type: news